This week we look at new cybersecurity standards for medical devices, a newly identified trigger for mood disorders, an implantable insulin delivery system and the exit of a major player in the race for an RSV vaccine. Finally, we continue to watch developments in diversity considerations for clinical ... READ MORE >
life sciences
5 things to know in life sciences: Week of March 20, 2023
This week we look at a collaboration between two large pharma companies on an Alzheimer's diagnostic, a major change in UK clinical trial regulations and a significant step to approval for an ALS (amyotrophic lateral sclerosis) drug. Finally, we highlight a promising breakthrough in brain implant ... READ MORE >
5 things to know in life sciences: Week of March 13, 2023
With the recent bank failures affecting many life sciences companies, it can be easy to lose sight of all the other industry news this week. So we will focus on the other stories you may have missed. In this issue we look at an increase in Nasdaq delisting notices among biotech companies, a major ... READ MORE >
5 things to know in life sciences: Week of March 6, 2023
This week we look at manufacturing investments taking place in life sciences, the Food and Drug Administration’s first Safer Technologies Program approval as well as the agency’s first full approval of a COVID-19 rapid antigen test. Finally, we highlight a story on the thriving canine population of ... READ MORE >
5 things to know in life sciences: Week of Feb. 27, 2023
This week we look at an artificial intelligence-powered platform that can detect early signs of heart disease, the Food and Drug Administration's treatment clearance that could help prevent migraine symptoms, and a revolutionary genomic medicine startup that raised $135 million. We also highlight ... READ MORE >
5 things to know in life sciences: Week of Feb. 20, 2023
This week we look at a new feature on the Apple Watch that could benefit diabetes patients, a newly approved hemophilia drug and calls for a new regulatory process for artificial intelligence-based medical technology. We also continue to explore concerns about clinical trial diversity. Finally, we ... READ MORE >
5 things to know in life sciences: Week of Feb. 13, 2023
This week we look at the Food and Drug Administration’s approval of an over-the-counter naloxone nasal spray, promising vaccines nearing approval to treat respiratory syncytial virus, and the FDA’s new guidance on diversity considerations for later-stage clinical trials. We also look at a new ... READ MORE >
5 things to know in life sciences: Week of Feb. 6, 2023
This week we look at the President’s State of the Union Address and his support to reduce drug prices, a concerning drug shortage in European countries, and a new brain-computer interface company that raised $41 million. We also review the recent acquisition of Cardiovascular Systems by Abbott. Finally, ... READ MORE >
5 things to know in life sciences: Week of Jan. 30, 2023
This week we look at how start-ups are rethinking how clinical trials are designed and managed to improve efficiency and accuracy. We also examine biosimilar versions of a blockbuster biologic, what to expect for cell and gene therapy companies, and why the U.S. government may pay lower prices after ... READ MORE >
5 things to know in life sciences: Week of Jan. 23, 2023
This week we look at an emerging funding source within biotechs, the hottest topics during the recent JP Morgan Healthcare Conference, a revolutionary app to automate insulin dosing, the struggle for Medicare reimbursement of obesity drugs, and the Food and Drug Administration’s final guidance on ... READ MORE >